Cargando…
Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
BACKGROUND: Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies...
Autores principales: | Nobrega, Franklin L., Ferreira, Débora, Martins, Ivone M., Suarez-Diez, Maria, Azeredo, Joana, Kluskens, Leon D., Rodrigues, Lígia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109716/ https://www.ncbi.nlm.nih.gov/pubmed/27842517 http://dx.doi.org/10.1186/s12885-016-2937-2 |
Ejemplares similares
-
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010) -
Loquat (Eriobotrya japonica) leaf extract inhibits the growth of MDA-MB-231 tumors in nude mouse xenografts and invasion of MDA-MB-231 cells
por: You, Mi-Kyoung, et al.
Publicado: (2016) -
Citral induced apoptosis in MDA-MB-231 spheroid cells
por: Nigjeh, Siyamak Ebrahimi, et al.
Publicado: (2018) -
Shock wave impact on the viability of MDA-MB-231 cells
por: Liao, Yingqian, et al.
Publicado: (2020) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017)